Follow
The pill was discovered in 1999, when its main purpose was to help women get rid of depression. The drug proved to be inefficient when it came about treating the depression, but women could observe a higher libido.
Since Saturday, the ”female” Viagra in on sale, despite persistent concerns.
The pills, also called Addyi, are meant to increase libido in women.
However, this drug poses a series of risks, such as adverse reactions, effectiveness, daily intake and negative effects when combined with alcohol.
For some, Addyi represents a major step in giving women the possibility to express their sexuality by increasing their desire to have sex. For other, on the other hand, the drug is considered a danger because of insufficient testing on women. More precisely, the testing included just 2 women out of 25 patients and 6 of them were affected by adverse reactions, such as the loss of consciousness and vertigo.
In 2010 and 2013, the FDA declined the drug twice, but Sprout resorted to a more belligerent campaign, involving women and making them ask for their right to have sexual freedom.
The contradictory discussions around this subject included a researcher that made the ”female” Viagra, Sprout’s CEO Cindy Whitehead and many women who believed that supporting this drug’s release would be a victory for them. At the opposite side, there were almost 200 scientists who tried to prove that this drug represents a danger for their lives.
The pill was discovered in 1999, when its main purpose was to help women get rid of depression. The drug proved to be inefficient when it came about treating the depression, but women could observe a higher libido.
With respect to this drug’s release, Whitehead declared that “One of my passions from the beginning is that there’s such a strong societal narrative that would reduce all things in the bedroom for men to biology and all things in the bedroom for women to psychology.”
Image Source: Pixabay
